Researchers belonging to IDIAP-accredited research groups or ICS primary care researchers will be eligible for a preferential rate.
Research projects proposed by research groups accredited by the IDIAP Jordi Gol will be given top priority by SIDIAP.
Researchers from research groups of other public research institutions can also apply for data to SIDIAP.
The regulatory framework that will govern access to SIDIAP data by these groups and/or institutions will be established through the signing of an agreement. Various aspects (including data security) will be taken into account for establishing the conditions of access to the data.
SIDIAP does not cede data to for-profit entities, but it can carry out quality research projects and deliver the relevant results reports at the end of the project, as long as these projects are required by a Regulatory Agency, such as the European Medicine Agency (EMA) or the Food and Drug Administration (FDA).
European projects will also be accepted if, although they are funded by non-profit organisations, there is public participation and a public call for proposals, such as the Innovative Medicines Initiative (IMI) projects.
In an initial phase, an IDIAP research team will be sought, and this will be responsible for defining the design of the study together with the external entity. Once the protocol has been finalised (and approved with the necessary changes by the SIDIAP and Ethics CC), the research team will carry out the project and deliver the different reports established in the agreement previously signed between the IDIAP Jordi Gol and the external entity. These studies will be subject to the rules of conduct dictated by the ENCEPP.
Key elements of collaboration